Thailand's king recovering after respiratory infection: palace
- Wall Street again marks new highs in post-election run
- Broadcom Ltd. (AVGO) Tops Q4 EPS by 11c
- Restoration Hardware (RH) Tops Q3 EPS by 4c; Guides Well Below the Street
- Unusual 11 Mid-Day Movers 12/8: (COOL) (TLRD) (DRAM) Higher; (SHIP) (OHRP) (MLSS) Lower
- After-Hours Stock Movers 12/08: (FNSR) (AVGO) (GLPG) Higher; (XTLY) (RH) (DLTH) Lower (more...)
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
BANGKOK (Reuters) - Thailand's 88-year-old King Bhumibol Adulyadej, the world's longest reigning monarch, is recovering after a respiratory infection, the palace said in a statement Sunday.
The king has no fever and a blood test showed a decrease in inflammation, it said, adding that an x-ray of his lungs showed no sign of inflammation.
It is the fourth health statement in over a week and follows a bulletin on Wednesday which said that the king had shown further improvement following a severe infection.
Doctors have stopped administering antibiotics to the king and will closely monitor his kidneys, the palace statement added. The king has been treated for various ailments during a year-long hospitalization in the Thai capital.
King Bhumibol is deeply revered in Thailand where he is accorded semi-divine status. Many Thais see him as a pillar of stability in a country subject to bouts of political instability and which has been ruled by a military junta since 2014.
The king was last seen in public on January 11.
(Reporting by Patpicha Tanakasempipat; Editing by Amy Sawitta Lefevre and Jon Boyle)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU launches new investigation into Chinese steel imports
- Macau authority lowers upper limit for ATM withdrawals per transaction
- Alabama executes 45-year-old man found guilty in the 1994 killing
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!